Chrome Extension
WeChat Mini Program
Use on ChatGLM

Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease

N. Lamichhane, N. Melas, V. Bergqvist, N.-P. Ekholm,O. Olén,J. F. Ludvigsson,H. Hjortswang,J. Marsal,C. Eriksson,J. Halfvarson

DIGESTIVE DISEASES AND SCIENCES(2024)

Cited 0|Views11
Key words
Inflammatory bowel disease,Vedolizumab,Real-world data,Observational study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined